The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network
在复发或难治性套细胞淋巴瘤中,利妥昔单抗、大剂量阿糖胞苷和地塞米松联合硼替佐米治疗——欧洲套细胞淋巴瘤网络的一项随机、开放标签III期试验
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-024-02254-2
Fischer, Luca; Jiang, Linmiao; Dürig, Jan; Schmidt, Christian; Stilgenbauer, Stephan; Bouabdallah, Krimo; Solal-Celigny, Philippe; Scholz, Christian W; Feugier, Pierre; de Wit, Maike; Trappe, Ralf Ulrich; Hallek, Michael; Graeven, Ullrich; Hänel, Mathias; Hoffmann, Martin; Delwail, Vincent; Macro, Margaret; Greiner, Jochen; Giagounidis, Aristoteles A N; Dargel, Beate; Durot, Eric; Foussard, Charles; Silkenstedt, Elisabeth; Weigert, Oliver; Pott, Christiane; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva; Ribrag, Vincent; Dreyling, Martin